Ivana De Risi

500 total citations
14 papers, 296 citations indexed

About

Ivana De Risi is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Ivana De Risi has authored 14 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Ivana De Risi's work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (4 papers). Ivana De Risi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (4 papers). Ivana De Risi collaborates with scholars based in Italy and China. Ivana De Risi's co-authors include Michele Guida, Sabino Strippoli, Simona De Summa, Letizia Porcelli, Simona Serratì, Amalia Azzariti, R. Fonte, Gabriella Guida, Alessandra Quarta and Rosa Maria Iacobazzi and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Cells.

In The Last Decade

Ivana De Risi

14 papers receiving 293 citations

Peers

Countries citing papers authored by Ivana De Risi

Since Specialization

Citations

This map shows the geographic impact of Ivana De Risi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivana De Risi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivana De Risi more than expected).

Fields of papers citing papers by Ivana De Risi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivana De Risi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivana De Risi. The network helps show where Ivana De Risi may publish in the future.

Co-authorship network of co-authors of Ivana De Risi

This figure shows the co-authorship network connecting the top 25 collaborators of Ivana De Risi. A scholar is included among the top collaborators of Ivana De Risi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivana De Risi. Ivana De Risi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patients 2025 ·Journal of Experimental & Clinical Cancer Research ·Amalia Azzariti, Simona De Summa, (unknown), Ivana De Risi, Giuseppe De Palma, R. Fonte, Rossella Fasano, Simona Serratì, Sabino Strippoli, Letizia Porcelli, Michele Guida	2
2	An artificial intelligence-based model exploiting H&E images to predict recurrence in negative sentinel lymph-node melanoma patients 2024 ·Journal of Translational Medicine ·Maria Colomba Comes, Livia Fucci, Sabino Strippoli, Samantha Bove, Gerardo Cazzato, (unknown), Ivana De Risi, (unknown), Annarita Fanizzi, (unknown), (unknown), Concetta Saponaro, (unknown), (unknown), Michele Guida, Alfredo Zito, Raffaella Massafra	4
3	Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma 2023 ·Journal of Experimental & Clinical Cancer Research ·Simona Serratì, R. Fonte, Letizia Porcelli, Simona De Summa, Ivana De Risi, Livia Fucci, Eustachio Ruggieri, (unknown), Sabino Strippoli, Rossella Fasano, (unknown), Gabriella Guida, Michele Guida, Amalia Azzariti	18
4	Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma 2022 ·Journal of Translational Medicine ·Michele Guida, Nicola Bartolomeo, Davide Quaresmini, Pietro Quaglino, Gabriele Madonna, Jacopo Pigozzo, Anna Maria Di Giacomo, Alessandro Marco Minisini, Marco Tucci, Francesco Spagnolo, Marcella Occelli, Laura Ridolfi, Paola Queirolo, Ivana De Risi, Monica Valente, (unknown), Vanna Chiarion‐Sileni, Paolo A. Ascierto, (unknown), Sabino Strippoli	19
5	Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma 2022 ·Molecular Cancer ·Simona Serratì, Michele Guida, R. Fonte, Simona De Summa, Sabino Strippoli, Rosa Maria Iacobazzi, Alessandra Quarta, Ivana De Risi, Gabriella Guida, Angelo Paradiso, Letizia Porcelli, Amalia Azzariti	116
6	A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients 2022 ·Scientific Reports ·Maria Colomba Comes, Livia Fucci, (unknown), Samantha Bove, (unknown), Ivana De Risi, Annarita Fanizzi, (unknown), Sabino Strippoli, Alfredo Zito, Michele Guida, Raffaella Massafra	21
7	Checkpoint Inhibitors Immunotherapy in Metastatic Melanoma: When to Stop Treatment? 2022 ·Biomedicines ·Ivana De Risi, (unknown), Michele Guida	9
8	No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study 2021 ·Cancers ·Michele Guida, Nicola Bartolomeo, Pietro Quaglino, Gabriele Madonna, Jacopo Pigozzo, (unknown), Alessandro Marco Minisini, Marco Tucci, Francesco Spagnolo, Marcella Occelli, Laura Ridolfi, Paola Queirolo, Ivana De Risi, Davide Quaresmini, Elisabetta Gambale, Vanna Chiarion‐Sileni, Paolo A. Ascierto, (unknown), Sabino Strippoli, (unknown)	19
9	Electrochemotherapy as a Trigger to Overcome Primary Resistance to Anti-PD-1 Treatment: A Case Report of Melanoma of the Scalp 2021 ·Frontiers in Oncology ·Davide Quaresmini, (unknown), Livia Fucci, Sabino Strippoli, Ivana De Risi, (unknown), (unknown), Gaetano Achille, (unknown), (unknown), (unknown), Michele Guida	6
10	Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma 2021 ·Cells ·Sabino Strippoli, Annarita Fanizzi, Antonio Negri, Davide Quaresmini, Annalisa Nardone, (unknown), (unknown), Raffaella Massafra, Ivana De Risi, Giacoma De Tullio, (unknown), Michele Guida	9
11	uPAR⁺ extracellular vesicles: a robust biomarker of resistance to checkpoint inhibitor immunotherapy in metastatic melanoma patients 2021 ·Journal for ImmunoTherapy of Cancer ·Letizia Porcelli, Michele Guida, Simona De Summa, R. Fonte, Ivana De Risi, (unknown), (unknown), Antonio Negri, Sabino Strippoli, Simona Serratì, Amalia Azzariti	37
12	Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers 2020 ·Therapeutic Advances in Medical Oncology ·Maristella Saponara, Laura Pala, Fabio Conforti, Marco Rubatto, Ivana De Risi, Francesco Spagnolo, Michele Guida, Paolo Bossi, Pietro Quaglino, Paola Queirolo	4
13	Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma 2020 ·Journal of Translational Medicine ·Sabino Strippoli, Livia Fucci, Antonio Negri, (unknown), M. Cisternino, (unknown), (unknown), Ivana De Risi, (unknown), Michele Guida	13
14	The Management of Oligoprogression in the Landscape of New Therapies for Metastatic Melanoma 2019 ·Cancers ·Michele Guida, Nicola Bartolomeo, Ivana De Risi, Livia Fucci, (unknown), (unknown), Eustachio Ruggieri, (unknown), Michele Traversa, Annalisa Nardone, (unknown), (unknown), (unknown), Stefania Tommasi, Sabino Strippoli	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact